Growth Metrics

Purple Biotech (PPBT) Income from Non-Controlling Interests (2017 - 2025)

Purple Biotech has reported Income from Non-Controlling Interests over the past 6 years, most recently at -$152000.0 for Q4 2022.

  • Quarterly Income from Non-Controlling Interests fell 547.06% to -$152000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$92000.0 through Dec 2022, down 192.0% year-over-year, with the annual reading at -$106000.0 for FY2025, 171.79% down from the prior year.
  • Income from Non-Controlling Interests was -$152000.0 for Q4 2022 at Purple Biotech, down from $25000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $520000.0 in Q2 2018 and troughed at -$152000.0 in Q4 2022.
  • The 5-year median for Income from Non-Controlling Interests is $29500.0 (2021), against an average of $126357.1.
  • Year-over-year, Income from Non-Controlling Interests surged 216.67% in 2020 and then crashed 547.06% in 2022.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $37000.0 in 2018, then tumbled by 67.57% to $12000.0 in 2019, then surged by 216.67% to $38000.0 in 2020, then decreased by 10.53% to $34000.0 in 2021, then crashed by 547.06% to -$152000.0 in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Income from Non-Controlling Interests are -$152000.0 (Q4 2022), $25000.0 (Q3 2022), and $16000.0 (Q2 2022).